In general, patients with the vasculitis phenotype usually carry variants that determine a residual ADA2 activity up to 40%–60% of the normal range (hypomorphic mutations) unlike patients with a prominent hematological phenotype in which the residual enzymatic activity is usually <3% (25). The gene discussed is ADA2; the disease is vasculitis.